No Such Thing as a Free Lunch (or Drug)

Finally, a published estimate of the impact of samples on drug spend. I have not dug through the article looking for study strengths and weakness, but it supports what drug companies already know; drug sampling of new drugs increases their business. More and more doctors have banned samples from their offices. But my doctor recently offered me samples of the latest and greatest cholesterol-lowering drug. Luckily, I have the expertise to say "No thanks, let's try a generic first."

Article Abstract:  Read more >>